- Home
- ORIS vs PYPD Comparison
ORIS vs PYPD Comparison
Compare ORIS & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- PYPD
- Stock Information
- Founded
- ORIS 2014
- PYPD 2008
- Country
- ORIS China
- PYPD Israel
- Employees
- ORIS N/A
- PYPD N/A
- Industry
- ORIS Farming/Seeds/Milling
- PYPD Medical/Dental Instruments
- Sector
- ORIS Consumer Staples
- PYPD Health Care
- Exchange
- ORIS Nasdaq
- PYPD Nasdaq
- Market Cap
- ORIS 30.4M
- PYPD 30.1M
- IPO Year
- ORIS 2024
- PYPD 2020
- Fundamental
- Price
- ORIS $1.12
- PYPD $2.99
- Analyst Decision
- ORIS
- PYPD Strong Buy
- Analyst Count
- ORIS 0
- PYPD 2
- Target Price
- ORIS N/A
- PYPD $10.50
- AVG Volume (30 Days)
- ORIS 208.4K
- PYPD 18.1K
- Earning Date
- ORIS 02-21-2025
- PYPD 02-12-2025
- Dividend Yield
- ORIS N/A
- PYPD N/A
- EPS Growth
- ORIS N/A
- PYPD N/A
- EPS
- ORIS 0.43
- PYPD N/A
- Revenue
- ORIS $16,745,999.00
- PYPD N/A
- Revenue This Year
- ORIS N/A
- PYPD N/A
- Revenue Next Year
- ORIS N/A
- PYPD N/A
- P/E Ratio
- ORIS $2.60
- PYPD N/A
- Revenue Growth
- ORIS N/A
- PYPD N/A
- 52 Week Low
- ORIS $0.94
- PYPD $2.37
- 52 Week High
- ORIS $56.01
- PYPD $6.58
- Technical
- Relative Strength Index (RSI)
- ORIS N/A
- PYPD 49.42
- Support Level
- ORIS N/A
- PYPD $2.89
- Resistance Level
- ORIS N/A
- PYPD $3.27
- Average True Range (ATR)
- ORIS 0.00
- PYPD 0.28
- MACD
- ORIS 0.00
- PYPD 0.00
- Stochastic Oscillator
- ORIS 0.00
- PYPD 45.89
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.